News & Analysis on Clinical Trial Services & Contract Research And Development
Ciphergen Biosystems has introduced its next generation ProteinChip System, Series 4000, primarily designed to enable rapid biomarker discovery and development of predictive, high throughput SELDI-based assays.
A novel approach to traditional drug design has led to a new drug which prevents eye scarring after glaucoma surgery. The discovery brings hope to half a million people in the UK who suffer from what is the most common cause of irreversible blindness...
Pharmaceutical instrument supplier Argonaut has introduced the Isolute PPT+ protein precipitation plates, created with the intention of accelerating drug research and development.
Pharmaceutical investment in antibiotic research and development (R&D) must be reinvigorated so doctors have access to medicines needed to combat the ever-growing threat of antibiotic resistant infections.
US biotechnology company Invitrogen reported record second-quarter revenue but warned that top-line growth for the rest of 2004 would be less than expected, citing an increasingly competitive business environment.